Oncolytics Biotech Inc. (TSX:ONC)
0.9600
-0.0100 (-1.03%)
Jun 20, 2025, 3:59 PM EDT
Oncolytics Biotech Employees
Oncolytics Biotech had 28 employees as of December 31, 2024. The number of employees decreased by 1 or -3.45% compared to the previous year.
Employees
28
Change
-1
Growth
-3.45%
Revenue / Employee
n/a
Profits / Employee
-1.13M CAD
Market Cap
85.27M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28 | -1 | -3.45% |
Dec 31, 2022 | 29 | 3 | 11.54% |
Dec 31, 2021 | 26 | 1 | 4.00% |
Dec 31, 2020 | 25 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Sienna Senior Living | 12,263 |
dentalcorp Holdings | 10,200 |
Green Thumb Industries | 4,800 |
Extendicare | 23,000 |
Cronos Group | 459 |
WELL Health Technologies | 1,507 |
Trulieve Cannabis | 6,000 |
Curaleaf Holdings | 5,519 |
Oncolytics Biotech News
- 9 days ago - Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs - PRNewsWire
- 4 weeks ago - Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities - PRNewsWire
- 5 weeks ago - Oncolytics Biotech Inc. (ONCY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum - PRNewsWire
- 5 weeks ago - Oncolytics Biotech Q1 2025 Earnings Preview - Seeking Alpha
- 5 weeks ago - A Look at Oncolytics Biotech's Upcoming Earnings Report - Benzinga
- 6 weeks ago - Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights - PRNewsWire
- 2 months ago - Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action - PRNewsWire